Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.08 USD | +0.97% | +9.47% | -30.43% |
25/03 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
25/03 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.43% | 394M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Esperion Therapeutics in Disagreement With Partner Over Cholesterol Drug Milestone Payments; Shares Fall Pre-Bell